BUSINESS Senores Pharmaceuticals reports Rs 664 crore total income for FY26, marking 65% growth 2:28 PM IST
BUSINESS Senores Pharmaceuticals announces strategic joint venture in U.S. for federal sector supplies Apr 3, 2026